0000899243-22-007015.txt : 20220218
0000899243-22-007015.hdr.sgml : 20220218
20220218160557
ACCESSION NUMBER: 0000899243-22-007015
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220216
FILED AS OF DATE: 20220218
DATE AS OF CHANGE: 20220218
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Brudnick Richard
CENTRAL INDEX KEY: 0001692359
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39615
FILM NUMBER: 22652686
MAIL ADDRESS:
STREET 1: BIOVERATIV INC.
STREET 2: 225 SECOND AVENUE
CITY: WALTHAM
STATE: MA
ZIP: 02451
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Codiak BioSciences, Inc.
CENTRAL INDEX KEY: 0001659352
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 35 CAMBRIDGEPARK DRIVE
STREET 2: SUITE 500
CITY: CAMBRIDGE
STATE: MA
ZIP: 02140
BUSINESS PHONE: 617-949-4100
MAIL ADDRESS:
STREET 1: 35 CAMBRIDGEPARK DRIVE
STREET 2: SUITE 500
CITY: CAMBRIDGE
STATE: MA
ZIP: 02140
FORMER COMPANY:
FORMER CONFORMED NAME: Codiak Biosciences, Inc.
DATE OF NAME CHANGE: 20151125
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-02-16
0
0001659352
Codiak BioSciences, Inc.
CDAK
0001692359
Brudnick Richard
C/O CODIAK BIOSCIENCES, INC.
35 CAMBRIDGEPARK DRIVE, SUITE 500
CAMBRIDGE
MA
02140
0
1
0
0
See Remarks
Stock Option (Right to Buy)
5.21
2022-02-16
4
A
0
10850
0.00
A
2032-02-15
Common Stock
10850
10850
D
Restricted Stock Units
2022-02-16
4
A
0
16275
0.00
A
Common Stock
16275
16275
D
25% of this option shall vest and become exercisable on February 16, 2023, with the remainder vesting in 12 equal quarterly installments thereafter.
Each restricted stock unit represents a contingent right to receive one share of common stock.
On February 16, 2022, the reporting person was granted 16,275 restricted stock units, vesting in four equal installments every six months beginning on the six month anniversary of the grant date.
Officer title: Chief Business Officer and Head of Corporate Strategy
/s/ Yalonda Howze, Attorney-in-Fact for Richard Brudnick
2022-02-18